INmune Bio is a diversified, clinical stage immunology company developing novel therapies targeting distinct parts of a patient’s innate immune system to fight disease Drug candidates INKmune and INB03 may be used to treat cancer; XPro1595 targets neuroinflammation as a cause of Alzheimer’s disease The company was awarded a $1 million “Part the Cloud” grant […]

The global hemp cannabidiol market is expected to top $22 billion worldwide by 2022, with CBD products comprising 25 percent of all cannabis sales Wildflower Brands is expanding the wellness reach of its cannabis products through a distribution pact with South African cannabis network provider Africann The company is also launching into Europe with a […]

Genprex, a clinical stage gene therapy company, will be utilizing the services of a leading pharmaceutical branding agency to oversee the naming process of its lead drug candidate, Oncoprex Addison Whitney has over 28 years of experience in the market, guiding pharmaceutical companies such as Merck, Celgene and Roche through the regulatory steps involved in […]

Beyond Meat’s financial results will be announced during a conference call scheduled for June 6 A live webcast will also be available via the company’s official website for investors interested in the financial information Beyond Meat’s portfolio of plant-based foods that replicate the taste and texture of meat has grown in popularity since the company’s […]

INmune Bio’s IPO closed February 1, 2019, with NASDAQ Capital Markets listing on February 4, 2019 Public clinical-stage immunology company with programs in oncology and neurodegenerative disease INmune Bio targets large markets with unsolved problems such as resistance to checkpoint inhibitor therapy, a fast-growing oncology market segment; MRD, the cause of cancer relapse; and neuroinflammation […]

Sproutly is a licensed producer with exclusive rights to Infusion Biosciences’ groundbreaking Aqueous Phytorecovery Process (“APP”) technology for naturally water-soluble cannabinoids The Canadian cannabis beverage market is estimated to exceed $4 billion by 2022 SRUTF executives were tapped to present APP technology at key cannabis conferences Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) is […]

Gene therapy could help overcome barriers that currently stand in the way of a cure for cancer Genprex is developing innovative, gene-based approaches toward the treatment of cancer, specifically non-small cell lung cancer Clinical trials so far have yielded encouraging data regarding the efficacy and safety of the company’s product candidate, Oncoprex Gene therapy could […]

Petroteq Energy completed a private placement of almost $1 million, generating funds that will be used to continue development of its proprietary technology for the environmentally-safe extraction of heavy oil Currently utilized at the Petroteq extraction facility in the Utah Asphalt Ridge pilot project, the technology could revolutionize the oil industry The company has already […]

Plus Products creates cannabis edibles to support healthier lifestyles The company offers top products in the adult-use, medical and CBD segments PLUS recently reported record revenues for Q4 2018 Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) is a foremost cannabis-branded products manufacturer with a mission to make cannabis safe and approachable. Based in San Mateo, […]

SHRG plans to focus on growth in Canada and other countries The company’s CEO is targeting new global markets; he credits the company’s U.S. success to Elepreneur independent sales associates and Elevacity Global LLC SHRG’s subsidiary scheduled an event in Ottawa prior to its entry into the Canadian market Sharing Services Global Corporation (OTCQB: SHRG) […]